Metabolism of endogenous and exogenous reproductive hormones

Obstetrics and Gynecology Clinics of North America

Volumn 29, Issue 3, 2002, Pages 425-436

  Grow, Daniel R ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; AROMATASE; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; ESTRONE; ETHINYLESTRADIOL; ETONOGESTREL; GESTODENE; LEVONORGESTREL; NORETHISTERONE; PROGESTERONE;

ADIPOSE TISSUE; CASTRATION; CONTRACEPTION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG HALF LIFE; ESTROGEN METABOLISM; FIRST PASS EFFECT; HORMONE METABOLISM; HORMONE SUBSTITUTION; MENOPAUSE; METABOLIC CLEARANCE RATE; OVARY; OVULATION; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW;

ADMINISTRATION, INTRAVAGINAL; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; HUMANS; MENOPAUSE; METABOLIC CLEARANCE RATE; PROGESTERONE;

EID: 0036739957     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8545(02)00009-8     Document Type: Review

References (44)

1. Baird DT, Fraser IS. Blood production and ovarian secretion rates of estradiol-17β and estrone in women throughout the menstrual cycle. J Clin Endocrinol Metab 1974;38:1009-17.
2. Fishman J, Bradlow HL, Gallagher TF. Oxidative metabolism of estradiol. J Biol Chem 1960;235:3104-7.
3. Longcope C, Franz C, Morello C, et al. Steroid and gonadotropin levels in women during the perimenopausal years. Maturitas 1986;8:189-96.
4. Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 1989;129:1120-30.
5. Vermeulen A. The hormonal activity of the postmenopausal ovary. J Clin Endocrinol Metab 1976; 42:247-53.
6. Hemsell DL, Grodin JM, Brenner PF, Siiteri PK, MacDonald PC. Plasma precursors of estrogen II. Correlation of the extent of conversion of plasma androstenedione to estrone with age. J Clin Endocrinol Metab 1974;38:476-9.
7. Bulun SE, Zeitoun K, Sasano H, Simpson E. Aromatase in aging women. Semin Reprod Endocrinol 1999;17:349-58.
8. Lobo RA, Cassidenti DL. Pharmacokinetics of oral 17β-estradiol. J Reprod Med 1992;37:77-84.
9. Anderson ABM, Sklovsky E, Sayers L, et al. Comparison of serum oestrogen concentrations in postmenopausal women taking oestrone sulphate and oestradiol. BMJ 1978;1:140-2.
10. Chung-Hsiu W, Motohashi T, Adbel-Rahman HA, Flickinger GL, Mikhail G. Free and protein bound plasma estradiol 17β during the menstrual cycle. J Clin Endocrinol Metab 1976;43:436-45.
11. Dunn JF, Nisula BC, et al. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 1981;53:58-68.
12. Longcope C. Metabolism of estrogens and progestogens. In: Fraser IS, editor. Estrogens and progestogens in clinical practice. Sydney, Australia: Churchill Livingstone; 1998. p. 89-93.
13. Longcope C. The metabolism of estrone sulfate in normal males. J Clin Endocrinol Metab 1972; 34:113-22.
14. Reed MJ, Fotherby K, Steele SJ. Metabolism of ethynyloestradiol in man. J Endocrinol 1972; 55:351-61.
15. King RJB, Dyer G, Collins WP, et al. Intracellular estradiol, estrone and estrogen receptor levels in endometria from postmenopausal women receiving estrogens and progestins. J Steroid Biochem 1980;13:377-82.
16. Martin PL, Yen SSC, Burnier AM, et al. Systemic absorption and sustained effects of vaginal estrogen creams. JAMA 1979;242:2699.
17. Barnes RB, Lobo RA. Pharmacology of estrogens. In: Mishel Jr DR, editor. Menopause: physiology and pharmacology. Chicago: Year Book Medical Publishers; 1987, p. 301-15.
18. Aedo AR, Sunden M, Landren BM, et al. Effect of orally administered oestrogens on circulating oestrogen profiles in postmenopausal women. Maturitas 1989;11:159.
19. Covin Jr. PL, Auerback BJ, Koritnik DR, et al. Differential effects of oral estrone versus 17β-estradiol on lipoproteins in postmenopausal women. J Clin Endocrinol Metab 1990;70:1568.
20. Lobo RA, Brenner P, Mishell Jr DR. Metabolic parameters and steroid levels in postmenopausal women receiving lower doses of natural estrogen replacement. Obstet Gynecol 1983;62:94.
21. Mashchak CA, Lobo RA, Dozono-Takano R, et al. Comparison of pharmacodynamic properties of various estrogen formulations. Am J Obstet Gynecol 1982;144:511.
22. Bhavnani BR. The saga of the ring B unsaturated equine estrogens. Endocr Rev 1988;9: 396-416.
23. Lobo RL, Nguyen HN, Eggena P, Brenner PF. Biologic effects of equilin sulfate in postmenopausal women. Fertil Steril 1988;49:235.
24. Schiff I, Tulchinsky D, Ryan KJ. Vaginal absorption of estrone and 17β-estradiol. Fertil Steril 1977;28:1063-6.
25. Mandel FP, Geola FL, Meldrum DR, et al. Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women. J Clin Endocrinol Metabol 1983;57:133.
26. Whitehead MI, Townsend PT, Gill DK, et al. Absorption and metabolism of oral progesterone. BMJ 1980;280:825.
27. Speert H. Local action of sex hormones. Physiol Rev 1948;28:23.
28. Yen SSC, Martin PL, Burnier NM, Czekala NM, Greeney Jr MO, Callantine MR. Circulating estradiol, estrone and gonadotropin levels following the administration of orally active 17β-estradiol in postmenopausal women. J Clin Endocrinol Metab 1975;40:518.
29. The Writing Group. Effects of hormone replacement therapy on endometrial histology in post-menopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA 1996;275:370-5.
30. Lin TJ, Billiar RB, Little B. Metabolic clearance rate of progesterone in the menstrual cycle. J Clin Endocrinol Metab 1972;35:879-86.
31. Briggs M. Contraceptive steroid binding to the human uterine progesterone receptor. Curr Med Res Opin 1975;3:95-8.
32. Juchem M, Pollow K. Binding of oral contraceptive progestogens to serum proteins and cytoplasmic receptor. Am J Obstet Gynecol 1990;163:2171-83.
33. Juchem M, Pollow K, Elger W, Hoffman G, Moebus V. Receptor binding of norgestimate: a new orally active synthetic progestational compound. Contraception 1993;47:283-94.
34. Stanczyk FZ. Structure-function relationships, potency, and pharmacokinetics of progestogens. In: Lobo RA, editor. Treatment of the postmenopausal women: basic and clinical aspects. New York: Raven Press; 1994. p. 69-89.
35. Whitehead MI, Townsend PT, Pryse-Davies J, Ryder TA, King RJB. Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. N Engl J Med 1981;305:1599-605.
36. King RJB, Whitehead MI. Assessment of the potency of orally administered progestins in women. Fertil Steril 1986;46:1062-6.
37. Dorflinger L. Relative potency of progestins used in oral contraceptives. Contraception 1985; 31:557-79.
38. Padwick ML, Endacott J, Matson C, Whitehead MI. Absorption and metabolism of oral progesterone when administered twice daily. Fertil Steril 1986;46:402-7.
39. de Ziegler D, Fanchin R. Progesterone and progestins: applications in gynecology. Steroids 2000;65:671-9.
40. de Ziegler D, Ferriani R, et al. Vaginal progesterone in menopause: crinone 4% in cyclical and constant combined regimens. Hum Reprod 2000;15:149-58.
41. Miles RA, Paulson RJ, et al. Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertil Steril 1994; 62:485-90.
42. Jarvela I, Tekay A, et al. The effect of levonorgestrel-releasing intrauterine system on uterine artery blood flow, hormone concentrations and ovarian cyst formation in fertile women. Hum Reprod 1998;13:3379-83.
43. Abdalla KA, Shabaan MM, et al. Interrelationship of serum levonorgestrel and sex hormone-binding globulin levels following vaginal and oral administration of combined steroid contraceptive tablets. Contraception 1992;45:111-8.
44. Souka AR, el Sokkary H, et al. The effect of vaginal administration of low-dose oral contraceptive tablets on human ovulation. Contraception 1986;33:365-71.